# A Study Investigating the Effects of Niagen™ in Healthy Adults.

> **NCT02712593** · PHASE2 · COMPLETED · sponsor: **KGK Science Inc.** · enrollment: 140 (actual)

## Conditions studied

- Bioavailability

## Interventions

- **DIETARY_SUPPLEMENT:** Niagen™ 100
- **DIETARY_SUPPLEMENT:** Niagen™ 300
- **DIETARY_SUPPLEMENT:** Niagen™ 1000
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02712593
- **Lead sponsor:** KGK Science Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-21
- **Primary completion:** 2017-03-17
- **Final completion:** 2017-04
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2018-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02712593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02712593, "A Study Investigating the Effects of Niagen™ in Healthy Adults.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02712593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*